Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA studyVincent Camus, Hervé Tilly, Chloé Antier et al.|Blood Advances|2021Cited by 51
High <i>PDL1/PDL2</i> gene expression correlates with worse outcome in primary mediastinal large B-cell lymphomaVincent Camus, Fabrice Jardin, Pierre‐Julien Viailly et al.|Blood Advances|2023Cited by 17
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5′RACEVincent Camus, Fabrice Jardin, Mathieu Viennot et al.|Blood Advances|2024Cited by 1
OUTCOMES AFTER FIRST‐LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDYVincent Camus, Hervé Tilly, Cédric Rossi et al.|Hematological Oncology|2021Cited by 0
13 | PROGNOSTIC VALUE OF THE COMBINATION OF RADIOMICS PARAMETERS MEASURED ON BASELINE FDG PET/CT IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMAPierre Decazes, Vincent Camus, Cédric Rossi et al.|Hematological Oncology|2025Cited by 0